We work with the medical community to transform the lives of patients through the best scientific, management and leadership talent worldwide.
The France edition of our Boyden Global Market Outlook, Talent-Led Growth, looks at talent strategy as a key component of business strategy, focuses on the healthcare & life sciences sector in France, both from a global and local perspective. Denis Sesboüé, a Boyden Partner in Paris, shares his insights on hiring the right leadership talent in France.
The Brazil edition of our Boyden Global Market Outlook, Talent-Led Growth, addressing concerns about talent in specific countries, focuses on the healthcare and life sciences industry in Brazil. It includes a Q&A with Alexandre Sabbag, a Boyden Partner in São Paulo, on the issues most often discussed in a life sciences senior executive search.
Executive Director of the Garvan Institute of Medical Research, Prof. John Mattick AO is one of Australia’s foremost research scientists. Having completed his studies in Sydney and Melbourne, and undertaking a postdoc at Baylor College of Medicine in Houston, Texas, Professor Mattick returned to Australia to work at the CSIRO Division of Molecular Biology in Sydney, before moving to the University of Queensland in 1988 where he progressed from the Foundation Professor of Molecular Biology to become the Foundation Director of the Institute for Molecular Bioscience and the Australian Genome Research facility, as well as NHMRC Australia Fellow.
In 2001 he was appointed an Officer of the Order of Australia for service to scientific research in the fields of molecular biology, genetics and biotechnology, and in 2012 took up his current post at the Garvan Institute of Medical Research in Sydney - one of Australia’s leading biomedical research institutes.
Mattick has made several seminal contributions to molecular biology, and over the past 20 years has pioneered a new view of the genetic programming of humans. He has published over 280 research articles and his work has received coverage in Nature, Science, Scientific American, New Scientist and The New York Times. He was recently named by NHMRC as one of the all-time high achievers in Australian health and medical research, and by Thomson Reuters as one of the world’s most influential scientific minds.